Cero Therapeutics Holdings Operating Expenses Growth & History (CERO)
Cero Therapeutics Holdings's operating expenses was $19.3M for fiscal 2025.
View full Cero Therapeutics Holdings company overviewCero Therapeutics Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $19.3M | $4.0M | +26.31% |
| 2024 | 2024-12-31 | $15.3M | $7.6M | +99.36% |
| 2023 | 2023-12-31 | $7.7M | $4.8M | +164.16% |
| 2022 | 2022-12-31 | $2.9M | $2.6M | +775.05% |
| 2021 | 2021-12-31 | $332,030 | — | — |
Cero Therapeutics Holdings quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.8M | −$877,325 | −18.57% |
| Q1 2026 | 2026-03-31 | $4.8M | −$104,803 | −2.12% |
| Q4 2025 | 2025-12-31 | $4.4M | — | — |
| Q3 2025 | 2025-09-30 | $4.4M | −$39,659 | −0.90% |
| Q2 2025 | 2025-06-30 | $4.7M | −$424,446 | −8.24% |
| Q1 2025 | 2025-03-31 | $5.0M | — | — |
| Q3 2024 | 2024-09-30 | $4.4M | $2.9M | +186.68% |
| Q2 2024 | 2024-06-30 | $5.1M | $2.7M | +113.29% |
| Q4 2023 | 2023-12-31 | $1.3M | −$13 | −0.00% |
| Q3 2023 | 2023-09-30 | $1.5M | $698,886 | +83.53% |
| Q2 2023 | 2023-06-30 | $2.4M | $2.0M | +540.97% |
| Q1 2023 | 2023-03-31 | $2.4M | $2.0M | +502.39% |
| Q4 2022 | 2022-12-31 | $1.3M | — | — |
| Q3 2022 | 2022-09-30 | $836,685 | $836,685 | — |
| Q2 2022 | 2022-06-30 | $376,580 | — | — |
| Q1 2022 | 2022-03-31 | $404,777 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
Cero Therapeutics Holdings operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Cero Therapeutics Holdings's operating expenses increased from $332,030 to $19.3M, a change of $19.0M. The latest reported quarter, Q2 2026, shows $3.8M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cero Therapeutics Holdings source filings ↗